Search

Displaying results 7341 - 7350 of 9313 in total
  1. Drug

    COVID-19 convalescent plasma

    go.drugbank.com/drugs/DB15692
    Investigational

    [L14333] Although there are no formal clinical trial results for the safety or efficacy of COVID-19 convalescent plasma, early results from 5000 patients under the FDA expanded access program suggest … COVID-19 convalescent plasma is plasma collected from patients who have acquired and subsequently recovered from COVID-19 and which contains antibodies against the causative agent SARS-CoV-2.

  2. Drug

    AVI-4020

    go.drugbank.com/drugs/DB05873
    Investigational

    AVI-4020 is a neugene antisense drug candidate for the treatment of patients with acute West Nile virus disease who have serious neurological impairment (WNV neuroinvasive disease).

  3. Drug

    FAV-201

    go.drugbank.com/drugs/DB06130
    Experimental

    FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.

  4. Drug

    2-phospho-D-glyceric acid

    go.drugbank.com/drugs/DB01709
    Experimental

    A 2-phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.

  5. Drug

    Afuresertib

    go.drugbank.com/drugs/DB11648
    Investigational

    Afuresertib has been used in trials studying the treatment of Cancer and Neoplasms, Haematologic.

  6. Drug

    PF-03758309

    go.drugbank.com/drugs/DB11775
    Investigational

    PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.

  7. Drug

    Farampator

    go.drugbank.com/drugs/DB15012
    Investigational

    Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).

  8. Drug

    Cicletanine

    go.drugbank.com/drugs/DB12766
    Investigational

    Cicletanine is under investigation for the treatment of Diabetes, Hypokalemia, Hyponatremia, and Arterial Hypertension.

  9. Drug

    Balaglitazone

    go.drugbank.com/drugs/DB12781
    Investigational

    Balaglitazone has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

  10. Drug

    GSK-1004723

    go.drugbank.com/drugs/DB12806
    Investigational

    Gsk1004723 has been investigated for the treatment of Allergic Rhinitis and Rhinitis, Allergic, Seasonal.